ALZpath just gave Alamar a bigger Alzheimer’s diagnostics role, but the regulatory test starts now
ALZpath expands its Alamar Biosciences deal into clinical diagnostics, opening a new path for pTau217 blood tests in Alzheimer’s disease.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Could Beckman Coulter’s Access p-Tau217 test make Alzheimer’s diagnosis faster and cheaper?
Beckman Coulter Diagnostics has secured European clearance for its automated Access p-Tau217 blood test, potentially widening access to Alzheimer’s biomarker testing while raising questions about reimbursement, intermediate results and clinical interpretation.